Cardiology and Therapy (Oct 2024)

A Response to: Letter to the Editor Regarding “Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)”

Sepideh Attal

Affiliations

Sepideh Attal: Pfizer PIO

DOI: https://doi.org/10.1007/s40119-024-00383-4
Journal volume & issue: Vol. 13, no. 4
pp. 815 – 817

Abstract

No abstracts available.

Published in Cardiology and Therapy

ISSN: 2193-8261 (Print); 2193-6544 (Online)
Publisher: Adis, Springer Healthcare
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: https://www.springer.com/journal/40119

About the journal